Načítá se...
Discovery and validation of new molecular targets in treating dyslipidemia: The role of human genetics
Several high profile failures of lipid-related therapeutics in clinical trials have led to intense interest in improved discovery and preclinical prioritization of potential targets. The careful study of patients with rare monogenic disorders has played a key role in establishing the causal role of...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2009
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3328807/ https://ncbi.nlm.nih.gov/pubmed/20211435 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tcm.2009.12.003 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|